{"pdb_id": "8zc6", "messages": [{"from": "human", "value": "<H>VQLVQSGAEVKKPGASVKVSCKASGYIFSDYNIHWVRQAPGQGLEWMGWISPDSDDTNYAQSFQGRVTMTRDTSITTVYMELSSLRSDDTAVYFCARSVGYCSLNSCQRWMWFDTWGQGALVTVSSA</H> <L>PVLTQPPSASGPPGQSVSISCSGSRSNIGTNFVYWYQQLPGAAPKLLIYKNDQRPSGVPERFFGSKSGTSASLAISGLRSEDEVDYYCAAWDDSLSGHVFGAGTKVTVLGQ</L> Why is this antibody resilient against common escape mutations?"}, {"from": "gpt", "value": "Its binding to a non-canonical epitope confers resilience against such mutations."}]}
{"pdb_id": "7amr", "messages": [{"from": "human", "value": "<H>QVQLVQSGAEVKKPGASVKVSCKASGYKFTGFVMHWVRQAPGQGLEWMGFINPYNDDIQSNERFRGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARGNGYNFDGAYRFFDFWGQGTMVTVSSA</H> <L>DIVMTQSPLSLPVTPGEPASISCRSSQRLVHSNGNTYLHWYLQKPGQSPRLLIYRVSNRFPGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCSQSTHVPYTFGQGTKLEIKRT</L> Which residues on TRBC1 does this antibody interact with?"}, {"from": "gpt", "value": "It interacts with Asn119 and Lys120."}]}
{"pdb_id": "8hhz", "messages": [{"from": "human", "value": "<H>QVQLVEWGAGLLKPSETLSLTCAVYGGSFSGYYWSWIRQPPGKGLEWIGLINHSGSTNYNPSLKSRVTISLDTSKNQFSLKLTSVTAADTAVYYCARGLGIFGVVTLSDVWGQGTTVTVSSA</H> <L>NFMLTQPHSVSESPGKTVTISCTGSSGSIASNYVQWYQQRPGSAPTTVIYEDNQRPSGVPDRFSGSIDSSSNSASLTISGLRTEDEADYYCQSYDSGIWVFGGGTKLTVLGQ</L> What type of virus does this antibody neutralize?"}, {"from": "gpt", "value": "It neutralizes SARS-CoV-2 and diverse sarbecoviruses."}]}
{"pdb_id": "4jpv", "messages": [{"from": "human", "value": "<H>QVQLLQSGAAVTKPGASVRVSCEASGYNIRDYFIHWWRQAPGQGLQWVGWINPKTGQPNNPRQFQGRVSLTRHASWDFDTYSFYMDLKALRSDDTAVYFCARQRSDYWDFDVWGSGTQVTVSSA</H> <L>DIQMTQSPSSLSASVGDTVTITCQANGYLNWYQQRRGKAPKLLIYDGSKLERGVPSRFSGRRWGQEYNLTINNLQPEDIATYFCQVYEFVVPGTRLDLKRT</L> Why are FWR mutations important for this antibody's function?"}, {"from": "gpt", "value": "They confer structural adaptability, enabling atypical antigen interactions."}]}
{"pdb_id": "7s7i", "messages": [{"from": "human", "value": "<H>EVQLVESGGGLVQPGGSLRLSCAASGFTFSTYSMNWVRQAPGKGLEWVSYISYRSRTIYYADSVKGRFTISRDNARNSLYLQMNSLRDEDTAVYYCARWGYGSGGFDYWGQGTLVTVSSA</H> <L>EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSFTFGPGTKVDIKRT</L> How does this antibody function as a neutralizing agent?"}, {"from": "gpt", "value": "It forms a conformational epitope that stabilizes the domain and inhibits receptor interactions."}]}
{"pdb_id": "3l5x", "messages": [{"from": "human", "value": "<H>VTLKESGPVLVKPTETLTLTCTVSGFSLSTYGMGVGWIRQPPGKALEWLAHIWWDDVKRYNPALKSRLTISKDTSKSQVVLTMTNMDPVDTATYYCARMGSDYDVWFDYWGQGTLVTVSSA</H> <L>EIVLTQSPATLSLSPGERATLSCRASKSISKYLAWYQQKPGQAPRLLIYSGSTLQSGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQHNEYPYTFGQGTKLEIKRT</L> How does this antibody remain relevant for asthma therapy despite structural shifts?"}, {"from": "gpt", "value": "It maintains therapeutic relevance by preserving neutralization efficacy and targeting asthma-related pathways."}]}
{"pdb_id": "8bbo", "messages": [{"from": "human", "value": "<H>QVQLVESGPGRVKPSQTLSLTCTVSGDSINSGINYWNWIRQPAGKELEWIGRIFTSGTTHYNPSLKSRVTISVDRSKNEFSLTLNSVTAADTAVYFCGRGGTDDYVDYWGQGTLVTVSSA</H> <L>AIQMTQSPSTLSASVGDRVTITCRASQDINSWLAWYQQKPGKAPKLLIYDASSLHSGVPTRFSGSGSGTEFTLTISSLQPDDFASYYCQQYKSYRTFGRGTKVEIKRT</L> Which residues does this antibody contact on the Delta RBD?"}, {"from": "gpt", "value": "It contacts residues 346, 444, 450, and 452."}]}
{"pdb_id": "4xvs", "messages": [{"from": "human", "value": "<H>QVQLLQSGAQVKKTGASMRISCKTSGYTFLNCPINWVRQAPGRGLEWMGWMKPRGGAVNYPQKFQGRVTMTRDMSTDTAFLDMSNLRSDDTAVYFCARGKYCTASDYYNWDFEHWGRGTLVTVSSP</H> <L>EIVLTQSPGTLSLSPGERATLSCRTSQYGSLAWYQQRPGQAPRLVIYGGSSRATGIPDRFTGSRSGADYTLTINRLEPEDFGIYYCQQYEFFGQGTKVEVDIK</L> What is the target of this antibody in HIV-1?"}, {"from": "gpt", "value": "It targets the CD4-binding site of gp120."}]}
{"pdb_id": "7uop", "messages": [{"from": "human", "value": "<H>QIQLVQSGPELKKPGETVKISCKASGYTFRNYGVNWVKQGPGKDLKWMGWINTLNGEPTYADDFKRRFAFSLETSATTAFLQINNLKNEDTATYFCARTFYDGYYYAMDYWGQGTSVTVS</H> <L>NVLTQSPTIMAASLGQKVTMTCSANSSVSSSYLHWYHQKSGASPKPLIHRTSNLASGVPARFIGSGSGTSFSLTISSVEAEDDATYYCQQWSGYPFITFGSGTKLEIK</L> How does this antibody inhibit viral entry?"}, {"from": "gpt", "value": "It disrupts conformational changes required for membrane fusion through π-π stacking and hydrogen bond interactions."}]}
{"pdb_id": "6xq0", "messages": [{"from": "human", "value": "<H>EVQLVESGGGLVRPGGSLTLTCAGSGFMFRSYDMHWVRQAAGKGLEWVAGMGKGGETFYAGSVKGRFTISRENARNSLYLQMHSLRAGDTAVYYCARALTEWLFQRGTRNHYYYGMDVWGQGTTITVSGA</H> <L>EIVLTQSPGTLSLSPGERATLSCRASQIIDNKYLAWYQQKPGQAPRLLIYGASNRATGIPDRFSGSGSGTEFTLIISRLEPEDLAVYYCQQFGSSVYTFGQGTRLEIKRT</L> What viral protein does this antibody target?"}, {"from": "gpt", "value": "It targets the hemagglutinin (HA) heads."}]}
{"pdb_id": "7nd7", "messages": [{"from": "human", "value": "<H>QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYTQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYSCARDMAFSMVRGSFDYWGQGTLVTVSS</H> <L>AVLTQPPSASGSPGQSVTISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYEVSKRPSGVPDRFSGSKSGNTASLTVSGLQAEDEADYYCSSYAGSNHWVFGGGTKLTVL</L> What part of SARS-CoV-2 does this antibody target?"}, {"from": "gpt", "value": "It targets the RBD at the neck and left shoulder epitopes, overlapping with the ACE2 binding site."}]}
{"pdb_id": "6xc2", "messages": [{"from": "human", "value": "<H>EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLDVYGLDVWGQGTTVTVSSA</H> <L>DIVMTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPKFTFGPGTKVEIKRT</L> What protein does this antibody target?"}, {"from": "gpt", "value": "It targets the SARS-CoV-2 spike protein (P0DTC2)."}]}
{"pdb_id": "5wb9", "messages": [{"from": "human", "value": "<H>QIELVQSGTEVKRPGASVRISCASSGYRFTNYFIHWVRQAPGRGLEWMGWMNPLHGGVNYSGRFQGRVTMTRDIYTETSFMVLSGLRSDDSAIYFCTRGRDGYDDGFHPWGQGTLVTVTAA</H> <L>SPSTLYASVGDKITITCRSSQSGWKAWYQQKPGKAPKLLIYKSSILETGVPSRFIGSDSGTEFTLTISSLQPDDFATYYCQHFETFGQGTRVQVRRT</L> What viral protein does this antibody target?"}, {"from": "gpt", "value": "It targets the CD4-binding site (CD4BS) of gp120."}]}
{"pdb_id": "7dk6", "messages": [{"from": "human", "value": "<H>QVQLKQSGPSLVQPSQSLSITCTVSGFSLTSYGVHWVRQSPGKGLEWLGVMWRGGNTDYNAAFMSRLSITKDNSKSQVFFKMNSLQTDDTAIYYCAKNGGAHAMDFWGQGTSVTVSSA</H> <L>NIVLTQSPASLAVSLGQRATISCRASESVDSYGNSFLHWYQQKPGQPPKLLIYLASNLESGVPARFSGSGSRTDFTLTIDPVEADDAATYYCQQNNEDPFTFGSGTKLEIKRA</L> What mediates the high-affinity binding of this antibody?"}, {"from": "gpt", "value": "Both heavy and light chain CDRs mediate its high-affinity binding."}]}
{"pdb_id": "6n5b", "messages": [{"from": "human", "value": "<H>EVQLQESGEGLVKPGGSLKLSCAASGFTFSNYDMSWVRQTPEKRLEWVAYISSGGDYIYYADTVKGRFTISRDNARNTLYLQMSSLKSEDTAMYYCTRNYYYGSLPVWFAYWGQGTLVTVSGA</H> <L>QAVVTQESALTTSPGETVTLTCRSSTGAVTTSNYANWVQEKPDHLFTGLIGGTNNRAPGVPARFSGSLIGDKAALTITGAQTEDEAIYFCALWYSNHSWVFGGGTKLTVLGQ</L> What epitope does this antibody target?"}, {"from": "gpt", "value": "A conserved, occluded epitope at the HA head interface of influenza virus hemagglutinin."}]}
{"pdb_id": "6hco", "messages": [{"from": "human", "value": "<H>VQLQESGPGLVKPSQSLSLTCTVTGFSITSDYAWNWIRQFPGKKLEWMGYINFDGGTTYNPSLRGRISITRDTSKNQFFLQLRSVTPEDTATYYCATFYGAKGTLDYWGQGTSVTVSS</H> <L>DIVLTQSPSSFSVSLGDRVTISCKASGYILNRLAWYQQKPGNAPRLLISGATSLETGFPSRFSGTGSGKDYTLSISSLQTEDVGTYYCQQYWSTPWTFGGGTKLEIR</L> Does this antibody disrupt substrate interaction with ABCG2?"}, {"from": "gpt", "value": "No, it slows ATP hydrolysis without disrupting substrate interaction."}]}
{"pdb_id": "7jmw", "messages": [{"from": "human", "value": "<H>QVQLVQSGAEVKKPGASVKVSCKASGYTFTSYYMHWVRQAPGQGLEWMGIINSSGGSTSYAQKFQGRVTMTRDTSTSTVYMELSSLRSEDTAVYYCARPPRNYYDRSGYYQRAEYFQHWGQGTLVTVSSA</H> <L>DIQLTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQRPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNPPLTFGGGTKLEIKRT</L> What is the primary function of this antibody?"}, {"from": "gpt", "value": "It induces coronary vasospasm."}]}
{"pdb_id": "9dnm", "messages": [{"from": "human", "value": "<H>EVQLVESGGGLVQPGGSLRLSCAASGFNVVDFSLHWVRQAPGKGLEWVAYISSSSGSTSYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARWGYWPGEPWWKAFDYWGQGTLVTVSSA</H> <L>DIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQYLYYSLVTFGQGTKVEIK</L> What is unique about this antibody's inhibitory mechanism?"}, {"from": "gpt", "value": "It is the first small-molecule inhibitor of β-arrestin and acts via an allosteric mechanism locking β-arrestin1 into an inactive-like state."}]}
{"pdb_id": "4xmm", "messages": [{"from": "human", "value": "<H>VQLVESGGGLVQPGGSLRLSCAASGFNVSYSSIHWVRQAPGKGLEWVASIYPYYGSTSYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARTGALDYWGQGTLVTVSSA</H> <L>DIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQPITFGQGTKVEIKRT</L> What broader utility does this antibody demonstrate?"}, {"from": "gpt", "value": "It exemplifies the utility of synthetic antibodies in resolving the structure of large, intricate protein assemblies."}]}
{"pdb_id": "1q1j", "messages": [{"from": "human", "value": "<H>EVQLVESGGGLVKPGGSLRLTCVASGFTFSDVWLNWVRQAPGKGLEWVGRIKSRTDGGTTDYAASVKGRFTISRDDSKNTLYLQMNSLKTEDTAVYSCTTDGFIMIRGVSEDYYYYYMDVWGKGTTVTVSSA</H> <L>QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVLWYQQFPGTAPKLLIYGNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYFCATWDSGLSADWVFGGGTKLTVLSQ</L> How does this antibody interact with the V3 loop?"}, {"from": "gpt", "value": "It forms a three-stranded mixed β sheet with the V3 loop."}]}

